Natacha Gassenbach
Public Communications Contact at BIOGEN INC.
Profile
Natacha Gassenbach is currently the Chief Communication Officer at Biogen, Inc. Prior to this, she held positions as Head of Corporate Affairs at Boston Scientific Corp., Baxalta, Inc., and Novartis Vaccines & Diagnostics, Inc. She also served as the Global Head of Communications & Investor Relations at Stallergenes Greer Ltd.
Gassenbach is a graduate of Sorbonne Université.
Natacha Gassenbach active positions
| Companies | Position | Start |
|---|---|---|
| BIOGEN INC. | Public Communications Contact | 2018-09-30 |
Former positions of Natacha Gassenbach
| Companies | Position | End |
|---|---|---|
| STALLERGENES GREER | Investor Relations Contact | 2018-09-30 |
| BOSTON SCIENTIFIC CORPORATION | Public Communications Contact | - |
Novartis Vaccines & Diagnostics, Inc.
 Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Public Communications Contact | - |
| BAXALTA INC | Public Communications Contact | - |
Training of Natacha Gassenbach
| Sorbonne Université | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BIOGEN INC. | Health Technology |
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| Private companies | 3 |
|---|---|
Stallergenes Greer Ltd.
 Stallergenes Greer Ltd. Pharmaceuticals: MajorHealth Technology Stallergenes Greer Ltd. is a healthcare company, which engages in the development and commercialization of allergy immunotherapy products and services. Its products include sublingual products, subcutaneous products, and veterinary products. The company was founded on December 6, 2013 and headquartered in London, the United Kingdom. | Health Technology |
Baxalta, Inc.
 Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
Novartis Vaccines & Diagnostics, Inc.
Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Health Technology |
- Stock Market
- Insiders
- Natacha Gassenbach
